Your browser doesn't support javascript.
loading
New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases.
Nemoz, Benjamin; Ternant, David; Bailly, Sébastien; Gautier-Veyret, Elodie; Jourdil, Jean-François; Bonaz, Bruno; Stanke-Labesque, Françoise.
Afiliação
  • Nemoz B; Laboratory of Pharmacology, Toxicology and Pharmacogenetics, Grenoble-Alpes University Hospital, Grenoble, France.
  • Ternant D; Laboratory of Pharmacology-Toxicology, CHRU de Tours University Hospital, France.
  • Bailly S; INSERM U1042, HP2, Grenoble, France.
  • Gautier-Veyret E; EFCR Laboratory, Pole Thorax et Vaisseaux, Grenoble Alpes University Hospital, Grenoble, France.
  • Jourdil JF; Laboratory of Pharmacology, Toxicology and Pharmacogenetics, Grenoble-Alpes University Hospital, Grenoble, France.
  • Bonaz B; INSERM U1042, HP2, Grenoble, France.
  • Stanke-Labesque F; Univ. Grenoble Alpes, Grenoble, France.
Br J Clin Pharmacol ; 85(4): 722-728, 2019 04.
Article em En | MEDLINE | ID: mdl-30575085
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Doença de Crohn / Monitoramento de Medicamentos / Infliximab Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Colite Ulcerativa / Doença de Crohn / Monitoramento de Medicamentos / Infliximab Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article